logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (ii) New outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates11.329.745.145.940.940.637.327.22321311429
Cocaine11.825.735.840.644.744.946.937.0204796157
Stimulants3.76.03.83.22.82.71.410.83373519
Hypnotics and sedatives0.70.71.11.84.05.89.719.2958313
Hallucinogens0.20.20.10.10.10.30.00.010141
Volatile substances0.80.20.10.10.10.30.00.218248
Cannabis 70.536.913.37.96.44.83.11.9230364901
Other substances 1.00.70.60.51.00.61.63.8548227
Total1137332916154556442300214407321447189023635

Notes:

 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain and Malta refer to 2006.Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009